What is the recommended workup and management for a suspected hiatal hernia?

Hiatal Hernia: Workup and Management

For suspected hiatal hernia, perform upper endoscopy with systematic evaluation of the gastroesophageal junction including Hill grade assessment, hernia size measurement, and evaluation for erosive esophagitis or Barrett's esophagus; if GERD symptoms are present, add prolonged wireless pH monitoring off PPI therapy to confirm pathologic reflux before committing to long-term medical or surgical management 1, 2.

Diagnostic Workup Algorithm

Initial Evaluation

• Upper GI endoscopy is the primary diagnostic modality 1, 2
• During endoscopy, systematically document:
  • Erosive esophagitis (Los Angeles classification if present)
  • Diaphragmatic hiatus assessment (Hill grade of flap valve)
  • Axial hiatus hernia length (measure in centimeters)
  • Barrett's esophagus screening (Prague classification with biopsy if present) 1

Critical technical point: Examine the hiatal hernia in retroflexion to accurately assess both hiatal size and integrity of the gastroesophageal junction 2.

Objective Reflux Testing

• If GERD symptoms are present or long-term PPI therapy is planned, perform 96-hour wireless pH monitoring off medication (preferred over 24-hour if available) 1
• This confirms pathologic reflux and phenotypes the disease before committing to chronic therapy
• For patients already on PPI with persistent symptoms, consider 24-hour pH-impedance monitoring on PPI to determine mechanism of refractory symptoms 1

Additional Studies for Surgical Candidates

• High-resolution manometry to exclude achalasia and assess esophageal peristaltic function 1
• Barium esophagram to define anatomical details, particularly for large or complex hernias 3
• Consider gastric emptying study if delayed emptying is suspected 1

Management Strategy

Medical Management (Type I Sliding Hernias with GERD)

Start with 4-8 week trial of single-dose PPI for typical reflux symptoms without alarm features 1.

• If partial response: escalate to twice-daily PPI or switch to more potent acid suppression
• If adequate response: taper to lowest effective dose 1
• Within 12 months of starting PPI, reassess appropriateness with objective testing if continuing long-term 1

Adjunctive pharmacotherapy should be phenotype-specific 1:

• Alginate antacids for breakthrough symptoms
• Nighttime H2 receptor antagonists for nocturnal symptoms
• Baclofen for regurgitation or belch-predominant symptoms
• Prokinetics only if coexistent gastroparesis is documented

Surgical Management Indications

Surgery is indicated for 1, 4, 5:

1. Symptomatic patients with confirmed pathologic GERD refractory to optimized medical therapy
2. Large paraesophageal hernias (>30% gastric contents in thorax, type III/IV, or giant hernias with defect >10 cm²) 6, 7
3. Complications: recurrent bleeding, ulcerations, strictures, or gastric volvulus 8, 4
4. Good operative risk asymptomatic patients with large paraesophageal hernias 4

Surgical Approach Selection

Laparoscopic repair is the gold standard 5, 3. The procedure must include 1, 3:

• Reduction of hernia contents
• Removal of hernia sac
• Crural repair/closure of hiatal defect
• Fundoplication (antireflux procedure)

Fundoplication type should be tailored 1:

• Partial fundoplication preferred in patients with esophageal hypomotility or impaired peristaltic reserve (reduces postoperative dysphagia risk)
• Nissen fundoplication for normal motility but carries higher dysphagia/gas-bloat risk 9

Alternative surgical options 1:

• Magnetic sphincter augmentation (often combined with crural repair in known hiatal hernia)
• Transoral incisionless fundoplication (endoscopic option for carefully selected patients without hiatal hernia or with minor crural defects)
• Roux-en-Y gastric bypass for obese patients with proven GERD (primary intervention) or as salvage in non-obese patients
• Avoid sleeve gastrectomy in GERD patients—it worsens reflux 1

Mesh Reinforcement Controversy

For giant/complex hernias (defect >10 cm², diameter ≥5 cm), recurrent hernias, or weak diaphragmatic crura, mesh-reinforced repair reduces recurrence risk 7. However, mesh use remains controversial due to unpredictable outcomes and complication risks 9. The evidence suggests:

• Synthetic meshes for giant/complex hernias
• Biological meshes to reduce foreign body reactions
• U-shaped mesh configuration preferred 7

Critical Pitfalls to Avoid

1. Do not commit to long-term PPI without objective confirmation of GERD—functional disorders mimic reflux and require different management 1
2. Do not perform surgery without excluding achalasia—this is a mandatory preoperative assessment 1
3. Do not ignore small hernias (<2 cm) if symptomatic—each diagnostic modality has limitations at this size 8
4. Do not perform Nissen fundoplication in patients with impaired esophageal motility—partial fundoplication reduces dysphagia complications 1, 9
5. Emphasize PPI safety to patients—address concerns about long-term use in shared decision-making 1